SEK216.50
2.26% today
Stockholm, Nov 26, 12:57 pm CET
ISIN
SE0000683484
Symbol
CEVI
Sector

CellaVision Stock price

SEK221.50
-39.00 14.97% 1M
-33.50 13.14% 6M
+9.50 4.48% YTD
+46.70 26.72% 1Y
-140.10 38.74% 3Y
-83.50 27.38% 5Y
+184.70 501.90% 10Y
Stockholm, Closing price Mon, Nov 25 2024
+4.50 2.07%
ISIN
SE0000683484
Symbol
CEVI
Sector

Key metrics

Market capitalization SEK5.28b
Enterprise Value SEK5.18b
P/E (TTM) P/E ratio 35.17
EV/FCF (TTM) EV/FCF 24.35
EV/Sales (TTM) EV/Sales 7.03
P/S ratio (TTM) P/S ratio 7.17
P/B ratio (TTM) P/B ratio 6.88
Dividend yield 1.02%
Last dividend (FY23) SEK2.25
Revenue growth (TTM) Revenue growth 17.20%
Revenue (TTM) Revenue SEK737.16m
EBIT (operating result TTM) EBIT SEK188.88m
Free Cash Flow (TTM) Free Cash Flow SEK212.77m
Cash position SEK137.66m
EPS (TTM) EPS SEK6.30
P/E forward 36.16
P/S forward 7.12
EV/Sales forward 6.98
Show more

Is CellaVision a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

CellaVision Stock Analysis

Unlock Scores for Free

Analyst Opinions

3 Analysts have issued a CellaVision forecast:

1x Buy
33%
2x Hold
67%

Analyst Opinions

3 Analysts have issued a CellaVision forecast:

Buy
33%
Hold
67%

Financial data from CellaVision

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
737 737
17% 17%
100%
- Direct Costs 243 243
22% 22%
33%
494 494
15% 15%
67%
- Selling and Administrative Expenses 179 179
31% 31%
24%
- Research and Development Expense 86 86
4% 4%
12%
229 229
9% 9%
31%
- Depreciation and Amortization 40 40
40% 40%
5%
EBIT (Operating Income) EBIT 189 189
32% 32%
26%
Net Profit 150 150
34% 34%
20%

In millions SEK.

Don't miss a Thing! We will send you all news about CellaVision directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

CellaVision AB engages in the provision of digital microscopy solutions for hematology laboratories. The firm's products include Analyzers, Instruments, DIFF-Line™ by CellaVision, Reagents, and Software and applications. It operates through the following geographical segments: Americas, APAC, and EMEA. The company was founded by Lars Christer Fedrik Fåhraeus on November 16, 1994 and is headquartered in Lund, Sweden.

Head office Sweden
CEO Simon Ostergaard
Employees 228
Founded 1994
Website www.cellavision.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today